Alexander I Spira (Alex Spira, Alexander Spira)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 39

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika Paige Hamilton, Toru Mukohara, Aaron E Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika Paige Hamilton, Toru Mukohara, Aaron E Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika Paige Hamilton, Toru Mukohara, Aaron E Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Christopher T Chen, Vishesh Khanna, Shivaani Kummar, Raghad M Abdul-Karim, David Sommerhalder, Anthony W Tolcher, Naoto Tada Ueno, S Lindsey Davis, Douglas W Orr, Erika Paige Hamilton, Manish R Patel, Alexander I Spira, Shekeab Jauhari, Vaia Florou, Maureen Duff, Rongda Xu, Jian Wang, Shravani R Barkund, Haiying Zhou, Aleksandr Pankov, Wayne Kong, Nadine S Jahchan, Erica L Jackson, Jessica D Sun, Melissa R Junttila, Pratik S Multani, Anneleen Daemen, Edna Chow-Maneval, Pamela N Munster
ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Nab-Paclitaxel in Patients with Advanced Solid Tumors. Cancer research communications (2024)
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika Paige Hamilton, Toru Mukohara, Aaron E Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim, Ying Cheng, Anna R Minchom, Melina E Marmarelis, Rachel E Sanborn, James Chih-Hsin Yang, Baogang Liu, Thomas John, Bartomeu Massuti, Alexander I Spira, Se-Hoon Lee, Jialei Wang, Juan Li, Caigang Liu, Silvia Novello, Masashi Kondo, Motohiro Tamiya, Ernesto Korbenfeld, Mor Moskovitz, Ji-Youn Han, Mariam Alexander, Rohit Joshi, Enriqueta Felip Font, Pei-Jye Voon, Pongwut Danchaivijitr, Ping-Chih Hsu, Felipe José Silva Melo Cruz, Thomas Wehler, Laurent Greillier, Encarnação Teixeira, Danny Nguyen, Joshua K Sabari, Angel Qin, Dariusz Mirosław Kowalski, Mehmet Ali Nahit Şendur, John Xie, Debopriya Ghosh, Ali A Alhadab, Nahor Haddish-Berhane, Pamela L Clemens, Patricia Lorenzini, Remy B Verheijen, Mohamed Gamil, Joshua M Bauml, Mahadi Baig, Antonio Passaro, null null
Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR -mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika Paige Hamilton, Toru Mukohara, Aaron E Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2- and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (19) (2024)
Jia Luo, Narjust Florez, Anjali Donnelly, Yanyan Lou, Kevin Lu, Patrick C Ma, Alexander I Spira, Debra Ryan, Hatim Husain
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS G12C -Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review. JCO precision oncology 8 (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Alessandro D Santin, Bradley R Corr, Alexander I Spira, Lyndsay Willmott, James Butrynski, Ka-Yu Tse, Jilpa Patel, Sabeen Mekan, Tia Wu, Kai-Wen Lin, Peiwen Kuo, Ecaterina E Ileana Dumbrava
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Alexander I Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz, Petros Nikolinakos, Patricia L Rich, Genevieve Jehl, Andreas Machl, Rena Ito, James L Gulley, Edmund S Kopetz
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial. The oncologist 28 (2) (2023)
Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross Andrew Soo, Danny Nguyen, Victor Ho Fun Lee, James Chih-Hsin Yang, Vamsidhar Velcheti, John M Wrangle, Mark A Socinski, Marianna Koczywas, John E Janik, Jeffrey Jones, Helena Alexandra Yu
Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Tanios S Bekaii-Saab, Rona Yaeger, Alexander I Spira, Meredith S Pelster, Joshua K Sabari, Navid Hafez, Minal Barve, Karen Velastegui, Xiaohong Yan, Aditya Shetty, Hirak Der-Torossian, Shubham Pant
Adagrasib in Advanced Solid Tumors Harboring a KRAS G12C Mutation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Cascone Tina, Gozde Kar, Jonathan D Spicer, María Del Rosario García-Campelo, Walter Weder, Davey B Daniel, David R Spigel, Maen Hussein, Julien Mazieres, Júlio Oliveira, Edwin H Yau, Alexander I Spira, Valsamo Anagnostou, Raymond Mager, Oday Hamid, Lin-Yang Cheng, Ying Zheng, Jorge M Blando, Tze Heng Tan, Michael Surace, Jaime Rodriguez-Canales, Vancheswaran Gopalakrishnan, Bret R Sellman, Italia Grenga, Yee Soo-Hoo, Rakesh Kumar, Lara McGrath, Patrick M Forde
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial. Cancer discovery (2023)
Marcelo Vailati Negrão, Alexander I Spira, Rebecca S Heist, Pasi A Janne, Jose M Pacheco, Jared Weiss, Shirish M Gadgeel, Karen Velastegui, Wenjing Yang, Hirak Der-Torossian, James G Christensen, Joshua K Sabari
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRAS G12C -Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Limin Zhang, Melissa Johnson, Minal Barve, Lyudmila Bazhenova, Marybeth McCarthy, Rowena Schwartz, Elise Horvath-Walsh, Karen Velastegui, Chunlin Qian, Alexander I Spira
Practical Guidance for the Management of Adverse Events in Patients with KRASG12C-Mutated Non-Small Cell Lung Cancer Receiving Adagrasib. The oncologist (2023)
Linda R Duska, Dmitriy Zamarin, Erika Paige Hamilton, Amit M Oza, Gini F Fleming, Alexander I Spira, Oladapo O Yeku, Debra L Richardson, Jackie Walling, Kerry Inokuchi, Bernice Matusow, Gideon Bollag, Elizabeth M Swisher
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer. JCO precision oncology 7 (2023)
Toshio Shimizu, Jacob M Sands, Kiyotaka Yoh, Alexander I Spira, Edward B Garon, Satoru Kitazono, Melissa Lynne Johnson, Funda Meric-Bernstam, Anthony W Tolcher, Noboru Yamamoto, Jon Greenberg, Yui Kawasaki, Hong Zebger-Gong, Fumiaki Kobayashi, Penny Phillips, Aaron E Lisberg, Rebecca S Heist
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Alexander I Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz, Petros Nikolinakos, Patricia L Rich, Genevieve Jehl, Andreas Machl, Rena Ito, James L Gulley, Edmund S Kopetz
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial. The oncologist 28 (2) (2023)
Cloud P Paweletz, Grace A Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C Chao, Alexander I Spira, Konstantinos Leventakos, Melissa Lynne Johnson, Sai-Hong Ignatius Ou, Gregory J Riely, Kenna Anderes, Wenjing Yang, James G Christensen, Pasi A Janne
Early changes in circulating cell free KRAS G12C predicts response to adagrasib in KRAS mutant non-small cell lung cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Saiama N Waqar, Clifford G Robinson, Anthony J Olszanski, Alexander I Spira, Melissa Hackmaster, Luisa Lucas, Laura Sponton, Hulin Jin, Ursula Hering, Damien Cronier, Marianna Grinberg, Annick Seithel-Keuth, Ivan Diaz-Padilla, Jordan D Berlin
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors. Investigational new drugs 40 (3) (2022)
Aung Naing, Fiona Thistlethwaite, Elisabeth G E De Vries, Ferry A L M Eskens, Nataliya Uboha, Patrick A Ott, Patricia LoRusso, Javier Garcia-Corbacho, Valentina Boni, Johanna Bendell, Karen A Autio, Manreet Randhawa, Greg Durm, Marta Gil-Martin, Mark Stroh, Alison L Hannah, Hendrik-Tobias Arkenau, Alexander I Spira
CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study. Journal for immunotherapy of cancer 9 (7) (2022)
Alexander I Spira, Michael S Wertheim, Edward J Kim, Benjamin Tan, Heinz-Josef Lenz, Petros Nikolinakos, Patricia L Rich, Genevieve Jehl, Andreas Machl, Rena Ito, James L Gulley, Edmund S Kopetz
Bintrafusp Alfa: A Bifunctional Fusion Protein Targeting PD-L1 and TGF-β, in Patients with Pretreated Colorectal Cancer: Results from a Phase I Trial. The oncologist (2022)
D Ross Camidge, Fabrice Barlesi, Jonathan Wade Goldman, Daniel Morgensztern, Rebecca S Heist, Everett E Vokes, Alexander I Spira, Eric Angevin, Wu-Chou Su, David S Hong, John H Strickler, Monica Motwani, Martin Dunbar, Apurvasena Parikh, Elysa Noon, Vincent Blot, Jun Wu, Karen Kelly
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido Lopez, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)
Bryan J Schneider, Jarushka Naidoo, Bianca D Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marianne J Davies, Marc S Ernstoff, Leslie A Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S R Mammen, Aung Naing, Loretta J Nastoupil, Tanyanika Phillips, Laura D Porter, Cristina A Reichner, Carole Seigel, Jung-Min Song, Alexander I Spira, Maria E Suarez-Almazor, Umang Swami, John A Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S Weber, Pauline Funchain, Kathryn Bollin
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Adi Diab, Scott S Tykodi, Gregory A Daniels, Michele Maio, Brendan D Curti, Karl D Lewis, Sekwon Jang, Ewa Anna Kalinka, Igor Puzanov, Alexander I Spira, Daniel C Cho, Shanhong Guan, Erika G Puente, Tuan Nguyen, Ute Hoch, Sue L Currie, Wei Lin, Mary A Tagliaferri, Jonathan Zalevsky, Mario Sznol, Michael E Hurwitz
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Alexander I Spira, Aaron R Hansen, Wael A Harb, Kelly K Curtis, Erina Koga-Yamakawa, Makoto Origuchi, Zhonggai Li, Bella Ertik, Walid L Shaib
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies. Targeted oncology 16 (4) (2021)
Bianca D Santomasso, Loretta J Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J Schneider, Milan Anadkat, Michael B Atkins, Kelly J Brassil, Jeffrey M Caterino, Ian Chau, Marianne J Davies, Marc S Ernstoff, Leslie A Fecher, Pauline Funchain, Ishmael Jaiyesimi, Jennifer S R Mammen, Jarushka Naidoo, Aung Naing, Tanyanika Phillips, Laura D Porter, Cristina A Reichner, Carole Seigel, Jung-Min Song, Alexander I Spira, Maria E Suarez-Almazor, Umang Swami, John A Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S Weber, Kathryn Bollin, Monalisa Ghosh
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (35) (2021)
Kathryn F Mileham, Suanna Steeby Bruinooge, Charu Aggarwal, Alicia L Patrick, Christiana Davis, Daniel J Mesenhowski, Alexander I Spira, Eric J Clayton, David Michael Waterhouse, Susan Moore, Abdul Rahman Jazieh, Ronald C Chen, Melinda Kaltenbaugh, Jen Hanley Williams, Julie R Gralow, Richard L Schilsky, Elizabeth Garrett-Mayer
Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry. JCO oncology practice (2021)